Clinical Trials for Day One Biopharmaceuticals

Explore 5 clinical trials worldwide

Showing 1-5 of 5 trials

Active filters:Status: Recruiting, Active, not recruiting, Enrolling by invitation, Not yet recruitingSponsor: Day One Biopharmaceuticals

Clinical Trials (5)

NCT06752681
To Evaluate the Safety, Tolerability, Pharmacokinetics and Antitumor Activity of DAY301 in Participants With Locally Advanced or Metastatic Solid Tumors
PHASE1Recruiting
254 participants
Started: Nov 18, 2024 · Completed: Dec 31, 2028
1 condition1 sponsor12 locations
NCT05566795
DAY101 vs. Standard of Care Chemotherapy in Pediatric Participants With Low-Grade Glioma Requiring First-Line Systemic Therapy (LOGGIC/FIREFLY-2)
PHASE3Recruiting
400 participants
Started: Feb 27, 2023 · Completed: Mar 31, 2030
3 conditions2 sponsors132 locations
NCT05465174
Tovorafenib for Treatment of Craniopharyngioma in Children and Young Adults
PHASE2Recruiting
57 participants
Started: Sep 12, 2022 · Completed: Mar 1, 2028
3 conditions2 sponsors14 locations
NCT04775485
A Study to Evaluate Tovorafenib in Pediatric and Young Adult Participants With Relapsed or Progressive Low-Grade Glioma and Advance Solid Tumors
PHASE2Recruiting
141 participants
Started: Apr 22, 2021 · Completed: May 31, 2027
2 conditions2 sponsors35 locations
NCT03429803
DAY101 In Gliomas and Other Tumors
PHASE1Active, not recruiting
44 participants
Started: Feb 27, 2018 · Completed: Dec 31, 2025
1 condition6 sponsors15 locations